Person-centered care for Graves' disease
Part of Eyes & vision, Hormones & metabolism, Immune system & allergy clinical trials.
This trial tests if a person-centered care approach improves well-being for people newly diagnosed with Graves' disease. You may receive extra support focused on your personal needs and goals.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- This is your first time being diagnosed with Graves' disease.
- Your blood tests show high FT4 and/or FT3 (thyroid hormones) and you have a positive TRAb test.
- You do not have moderate or severe eye symptoms from Graves'.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at people newly diagnosed with Graves' disease to see who might develop thyroid eye disease, a condition that can affect the eyes. It aims to find early signs so that treatment can be started sooner.
This early-phase trial tests a new type of treatment called CAR-T cells (special immune cells made in a lab) to target and calm down the overactive immune system in people with severe Graves' disease that hasn't improved with standard medicines. It may offer a new option for those who have been on treatment for years or have had multiple relapses.
This study tests efgartigimod, a new medicine given by injection under the skin, to see if it can help control Graves' disease (an overactive thyroid condition). The goal is to reduce the need for other thyroid medications or help people stop taking them.
This trial tests a personalized approach to treat thyroid disorders, either Graves’ disease or certain thyroid cancers that may need radioactive iodine treatment. It may help by matching treatment to your specific test results and needs.
This trial tests a new medicine called REGN24493 that may help control Graves' disease by blocking a specific receptor in the body. It is designed for adults who have been diagnosed with Graves' disease and are currently stable on their thyroid levels.
This trial tests a new type of cell therapy called CAR-T cells made from a donor. The cells target B cells that may drive Graves' disease. It's for people whose Graves' disease has not gotten better with usual treatments.
Hear when a new Graves Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.